Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
coxerit filmuhúðuð tafla 30 mg
williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 30 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
coxerit filmuhúðuð tafla 120 mg
williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 120 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
coxerit filmuhúðuð tafla 60 mg
williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 60 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
coxerit filmuhúðuð tafla 90 mg
williams & halls ehf - etoricoxibum inn - filmuhúðuð tafla - 90 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
etoricoxib krka filmuhúðuð tafla 90 mg
krka d.d. novo mesto* - etoricoxibum inn - filmuhúðuð tafla - 90 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
etoricoxib krka filmuhúðuð tafla 30 mg
krka d.d. novo mesto* - etoricoxibum inn - filmuhúðuð tafla - 30 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
etoricoxib krka filmuhúðuð tafla 120 mg
krka d.d. novo mesto* - etoricoxibum inn - filmuhúðuð tafla - 120 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
etoricoxib krka filmuhúðuð tafla 60 mg
krka d.d. novo mesto* - etoricoxibum inn - filmuhúðuð tafla - 60 mg
Unión Europea -
islandés -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celecoxib actavis hart hylki 200 mg
actavis group ptc ehf. - celecoxibum inn - hart hylki - 200 mg